Loss of volunteer blood donors because of unconfirmed enzyme immunoassay screening results

Transfusion

Volumn 37, Issue 2, 1997, Pages 199-205

  Ownby, H E ^a   Korelitz, J J ^b   Busch, M P ^c,d   Williams, A E ^a,e   Kleinman, S H ^b   Gilcher, R O ^f   Nourjah, P ^b  

^a AMERICAN RED CROSS BLOOD SERVICES   (United States)

^b WESTAT   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Blood Centers of the Pacific   (United States)

^e HOLLAND LABORATORY   (United States)

^f Oklahoma Blood Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD DONOR; CROSS REACTION; DEMOGRAPHY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SCREENING; SEROLOGY;

EID: 0031052433     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1997.37297203524.x     Document Type: Article

References (32)

1. Kakaiya R, Gudino M, Miller WV. Interpreting western blot indeterminate HIV antibody tests (letter). Lancet 1990;335:292.
2. Knuver-Hopf J, Heinze H, Lambrecht B, et al. Blood donations indeterminate in HIV-1 western blot analysed by IgM immunoblot and polymerase chain reaction. Vox Sang 1993;64:89-93.
3. Busch MP, Kleinman SH, Williams AE, et al. Frequency of human immunodeficiency virus (HIV) infection among contemporary anti-HIV-1 and anti-HIV-1/2 supplemental test-indeterminate blood donors. Transfusion 1996;36:37-44.
4. Jackson JB, Hanson MR, Johnson GM, et al. Long-term follow-up of blood donors with indeterminate human immunodeficiency virus type 1 results on Western blot. Transfusion 1995;35:98-102.
5. Lipka JJ, Young KK, Kwok SY, et al. Significance of human T-lymphotropic virus type I indeterminant serological findings among healthy individuals. Vox Sang 1991;61:171-6.
6. Celum CL, Coombs RW, Jones M, et al. Risk factors for repeatedly reactive HIV-1 EIA and indeterminate western blots. A population-based case-control study. Arch Intern Med 1994;154:1129-37.
7. Calabrese LH. Indeterminate reactors to tests for human immunodeficiency virus (HIV) (letter). Ann Intern Med 1989;111:95.
8. Sullivan JF, Kessler HA, Sha BE. False-positive HIV test: implications for the patient (letter). JAMA 1993;269:2847.
9. Jackson JB. Human immunodeficiency virus (HIV)-indeterminate Western blots and latent HIV infection. Transfusion 1992;32:497-9.
10. Eble BE, Busch MP, Khayam-Bashi H, et al. Resolution of infection status of human immunodeficiency virus (HIV)-seroindeterminate donors and high-risk seronegative individuals with polymerase chain reaction and virus culture: absence of persistent silent HIV type 1 infection in a high-prevalence area. Transfusion 1992;32:503-8.
11. Moncharmont P, Voisin A, Chevre C, et al. Markers of hepatitis B and hepatitis C viruses in blood donors with positive or indeterminate immunoblot tests for human retroviruses (letter). Presse Med 1990;19:1905.
12. Nicholson S, Leslie DE, Efandis T, et al. Hepatitis C antibody testing: problems associated with non-specific binding. J Virol Methods 1991;33:311-7.
13. Zuck TF, Thomson RA, Schreiber GB, et al. The Retrovirus Epidemiology Donor Study (REDS): rationale and methods. Transfusion 1995;35:944-51.
14. SAS/STAT user's guide, version 6.4th ed. Cary, NC: SAS Institute, 1989.
15. McCullough J. The nation's changing blood supply system. JAMA 1993;269:2239-45.
16. Williams AE, Kleinman S, Gilcher RO, et al. The prevalence of infectious disease markers in directed vs. homologous blood donations (abstract). Transfusion 1992;32(Suppl):45S.
17. Sayre KR, Dodd RY, Tegtmeier G, et al. False-positive human immunodeficiency virus type 1 Western blot tests in noninfected blood donors. Transfusion 1996;36:45-52.
18. Leitman SF, Klein HG, Melpolder JJ, et al. Clinical implications of positive tests for antibodies to human immunodeficiency virus type 1 in asymptomatic blood donors. N Engl J Med 1989;321:917-24.
19. Dodd RY, Houlihan K, Lamberson HV. The specificity of enzyme immunoassays for antibodies to human immunodeficiency virus: impact on record and donor management (letter). Transfusion 1993;33:693.
20. Tobler LH, Busch MP, Wilber J, et al. Evaluation of indeterminate c22-3 reactivity in volunteer blood donors. Transfusion 1994;34:130-4.
21. Kleinman SH, Kaplan JE, Khabbaz RF, et al. Evaluation of a p21e-spiked western blot (immunoblot) in confirming human T-cell lymphotropic virus type I or II infection in volunteer blood donors. The Retrovirus Epidemiology Donor Study Group. J Clin Microbiol 1994;32:603-7.
22. Celum CL, Coombs RW, Lafferty W, et al. Indeterminate human immunodeficiency virus type I western blots: seroconversion risk, specificity of supplemental tests, and an algorithm for evaluation. J Infect Dis 1991;164:656-64.
23. 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome. J Exp Med 1988;167;914-23.
24. Sayers MH, Beatty PG, Hansen JA. HLA antibodies as a cause of false-positive reactions in screening enzyme immunoassays for antibodies to human T-lymphotropic virus type III. Transfusion 1986;26:113-5.
25. 4 antibodies cause positive HTLV-III antibody ELISA results (letter). Lancet 1985;1:1222-3.
26. Agius G, Biggar RJ, Alexander SS, et al. Human T lymphotropic virus type I antibody patterns: evidence of difference by age and risk group. J Infect Dis 1988;158:1235-44.
27. Murphy EL, Bryzman S, Williams AE, et al. Demographic determinants of hepatitis C virus seroprevalence among blood donors. JAMA 1996;275:995-1000.
28. Mac Kenzie WR, Davis JP, Peterson DE, et al. Multiple false-positive serologic tests for HIV, HTLV-1, and hepatitis C following influenza vaccination, 1991. JAMA 1992;268:1015-7.
29. Buffington J, Shapiro CN, Holman RC, et al. Multiple unconfirmed-reactive screening tests for viral antibodies among blood donors. Transfusion 1994;34:371-5.
30. Simonson L, Buffington J, Shapiro CN, et al. Multiple false reactions in viral antibody screening assays after influenza vaccination. Am J Epidemiol 1995;141:1089-96.
31. Genesca J, Shih JW, Jett BW, et al. What do western blot indeterminate patterns for human immunodeficiency virus mean in EIA-negative blood donors? Lancet 1989;334:1023-5.
32. Fang C, Bettigole R, Kratzel R, et al. HIV-1 WB indeterminate reactivity among different donor sample populations (abstract). Transfusion 1993;33(Suppl):37S.